Company Filing History:
Years Active: 2021-2024
Title: The Innovative Contributions of Paolo Monelli
Introduction
Paolo Monelli is a notable inventor based in Rivoli, Italy, recognized for his significant contributions to the field of medical devices, particularly in heart valve prostheses. With a total of two patents to his name, Monelli has made strides in improving cardiac health through innovative designs.
Latest Patents
Monelli's latest patents include a two-part mitral valve and implant method. This invention features a multiple component heart valve prosthesis that consists of an abutment ring and a removable bioprosthetic heart valve. The abutment ring is designed for attachment at a heart valve annulus location and incorporates a locking system. The removable bioprosthetic heart valve includes a valve frame and at least one locking feature, which is configured to engage with the locking system. This design allows the bioprosthetic heart valve to be rotated relative to the abutment ring, transitioning the locking feature from a disengaged position to an engaged position. In the disengaged position, the bioprosthetic heart valve can be removed from the abutment ring, while in the engaged position, it is securely restrained from axial movement.
Career Highlights
Monelli is currently associated with Corcym S.r.l., a company that focuses on developing innovative solutions in the field of cardiac surgery. His work has been instrumental in advancing the technology surrounding heart valve replacements, contributing to better patient outcomes.
Collaborations
Throughout his career, Monelli has collaborated with esteemed colleagues such as Silvano Moiso and Felice Giuseppe Carlino. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Paolo Monelli's contributions to the field of medical devices, particularly in heart valve technology, highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in cardiac health.